De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism.
De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism.
复制标题
DOI:
10.1007/s10048-015-0466-9
复制
发表时间:
2016-01
期刊:
影响因子:
2.2
通讯作者:
Chung WK
中科院分区:
文献类型:
--
作者:
Shang L;Henderson LB;Cho MT;Petrey DS;Fong CT;Haude KM;Shur N;Lundberg J;Hauser N;Carmichael J;Innis J;Schuette J;Wu YW;Asaikar S;Pearson M;Folk L;Retterer K;Monaghan KG;Chung WK
Protein phosphatase 2A (PP2A) is a heterotrimeric protein serine/threonine phosphatase and is involved in a broad range of cellular processes. PPP2R5D is a regulatory B subunit of PP2A and plays an important role in regulating key neuronal and developmental regulation processes such as PI3K/AKT and GSK3β-mediated cell growth, chromatin remodeling and gene transcriptional regulation. Using WES, we identified four de novo variants in PPP2R5D in a total of seven unrelated individuals with ID and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, seizures and dysmorphic features. Among the four variant, two have been previously reported, and two are novel. All four amino acids are highly conserved among the PP2A subunit family, and all change a negatively charged acidic glutamic acid (E) to a positively charged basic lysine (K), and are predicted to disrupt the PP2A subunits binding and impair the dephosphorylation capacity. Our data provides further support for PPP2R5D as a genetic cause of ID.